Lilly are off again only one day after the announcement of the failure of solanezumab at CTAD
When will they learn protein plaques is not the answer!!!
>>>
http://www.fiercebiotech.com/biotech/after-ph3-failures-lilly-signs-new-alzheimer-s-drug-pact-astrazeneca
0 Comments